Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Safety and Efficacy Study of Oral ELND005 (AZD-103) in Alzheimer's Disease

NCT00568776 is registered in ClinicalTrials.gov with OPKO Health, Inc. as lead sponsor.

NCT NCT00568776
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00568776 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Safety and Efficacy Study of Oral ELND005 (AZD-103) in Alzheimer's Disease
Lead sponsor
OPKO Health, Inc.
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2007
Completion date
May 31, 2010
Enrollment
353 (actual)
Sites
62

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease